LABORATORY RESEARCH Regulation of Glycolysis by Pdk Functions as a Metabolic Checkpoint for Cell Cycle Quiescence in Hematopoietic Stem Cells Mammalian hematopoietic stem cells (HSCs) maintain cell cycle quiescence in a hypoxic microenvironment. It has been proposed that HSCs exhibit a distinct metabolic phenotype under these conditions. Scientists directly investigated this idea using metabolomic analysis and found that HSCs generate adenosine-5′-triphosphate by anaerobic glycolysis through a pyruvate dehydrogenase kinase (Pdk)-dependent mechanism. [Cell Stem Cell] Abstract | Graphical Abstract The Cell Fate Determinant Llgl1 Influences HSC Fitness and Prognosis in Acute Myeloid Leukemia Researchers found evidence that the cell fate determinant Llgl1 (lethal giant larvae homolog 1) plays an important role in regulation of hematopoietic stem cells. [J Exp Med] Abstract Circulating CD34+ Progenitor Cell Frequency Is Associated with Clinical and Genetic Factors Researchers examined clinical and genetic characteristics associated with circulating CD34+ cell frequency in a large, community-based sample of 1,786 Framingham Heart Study participants. [Blood] Abstract TLR9-Mediated siRNA Delivery for Targeting of Normal and Malignant Human Hematopoietic Cells In Vivo Researchers recently showed that Toll-like receptor 9 (TLR9) agonists, CpG oligonucleotides, can be used for targeted siRNA delivery to mouse immune cells. Here, they demonstrated that a similar strategy allows for target gene silencing in both normal and malignant human TLR9-positive hematopoietic cells in vivo. [Blood] Abstract ADAR1 Promotes Malignant Progenitor Reprogramming in Chronic Myeloid Leukemia Whole-transcriptome sequencing of normal, chronic phase, and serially transplantable blast crisis chronic myeloid leukemia (CML) progenitors revealed increased IFN-γ pathway gene expression in concert with BCR-ABL amplification, enhanced expression of the IFN-responsive adenosine deaminase acting on RNA-1 (ADAR1) p150 isoform, and a propensity for increased adenosine-to-inosine RNA editing during CML progression. [Proc Natl Acad Sci USA] Abstract | Full Article | Press Release Alcam Regulates Long-Term Hematopoietic Stem Cell Engraftment and Self-Renewal Investigators showed that activated leukocyte cell adhesion molecule (Alcam) is differentially regulated in adult hematopoiesis and is highly expressed in long-term hematopoietic stem cells where its level progressively increases with age. [Stem Cells] Abstract Candida albicans Stimulates In Vivo Differentiation of Hematopoietic Stem and Progenitor Cells toward Macrophages by a TLR2 Dependent Signaling Using an in vivo model of hematopoietic stem and progenitor cells (HSPCs) transplantation, researchers report for the first time that HSPCs sense C. albicans in vivo and subsequently are directed to produce macrophages by a Toll-like receptor-2 (TLR2) dependent signaling. [Cell Microbiol] Abstract Donor Th17 Cells and IL-21 May Contribute to the Development of Chronic Graft-versus-Host Disease after Allogeneic Transplantation The roles of Th17 cells and IL-21 in the pathogenesis of chronic graft-versus-host disease (cGvHD) in patients who undergo allogeneic transplantation are still unknown. The authors examined this question by monitoring eight patients with new-onset cGvHD for the presence of Th17 cells, Th1 cells and IL-21. [Eur J Immunol] Abstract TLR4 Inactivation Protects from Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation To clarify the role of Toll-like receptor 4 (TLR4) in the development of acute graft-versus-host disease (GvHD), researchers used a TLR4-knockout mouse GvHD model and analyzed the underlying immunological mechanisms. [Cell Mol Immunol] Abstract CLINICAL RESEARCH The Efficacy of Selenium in Prevention of Oral Mucositis in Patients Undergoing Hematopoietic SCT: A Randomized Clinical Trial Researchers performed a double-blind, randomized, placebo-controlled study to evaluate the efficacy of selenium on the prevention of oral mucositis in 77 patients with leukemia, undergoing allogeneic hematopoietic SCT. [Bone Marrow Transplant] Abstract Phase II Pilot Study of Oral Dasatinib in Patients with Higher-Risk Myelodysplastic Syndrome (MDS) Who Failed Conventional Therapy Given evidence for the role of Src family kinases, especially Lyn kinase, in myeloblast proliferation and the in vitro inhibitory activity of dasatinib on Src and Lyn, the authors conducted a Phase II study to assess overall response to 100mg/day dasatinib in patients with higher-risk myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia, or acute myeloid leukemia arising from MDS and who had failed prior treatment with azanucleoside analogs. [Leuk Res] Abstract |